GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (MEX:GRAL) » Definitions » Inventories, Raw Materials & Components

GRAIL (MEX:GRAL) Inventories, Raw Materials & Components : MXN389 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Inventories, Raw Materials & Components?

GRAIL's inventories, raw materials & components for the quarter that ended in Dec. 2024 was MXN389 Mil.

GRAIL's quarterly raw materials declined from Jun. 2024 (MXN467 Mil) to Sep. 2024 (MXN418 Mil) and declined from Sep. 2024 (MXN418 Mil) to Dec. 2024 (MXN389 Mil).

GRAIL's annual raw materials declined from Dec. 2022 (MXN385 Mil) to Dec. 2023 (MXN368 Mil) but then increased from Dec. 2023 (MXN368 Mil) to Dec. 2024 (MXN389 Mil).


GRAIL Inventories, Raw Materials & Components Historical Data

The historical data trend for GRAIL's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Inventories, Raw Materials & Components Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
- - 385.14 368.26 388.58

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 368.26 358.11 467.27 417.69 388.58

GRAIL Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


GRAIL Business Description

Industry
Traded in Other Exchanges
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.